Skip to main content
Journal of Clinical Pathology logoLink to Journal of Clinical Pathology
. 1964 Jan;17(1):14–26. doi: 10.1136/jcp.17.1.14

Investigations into the Euglena method for the assay of the vitamin B12 in serum

Barbara B Anderson 1
PMCID: PMC480664  PMID: 14099996

Abstract

Details are given of a modified Euglena method for the assay of B12 in serum. Serum in very small quantities is usually inhibitory to the growth of the Euglena. In general, this inhibition is most marked when the organism is growing prolifically. For estimating serum B12 values, a standard curve is used from B12 standards containing 0·01 ml. of serum of low B12 content, so that growth in test serum solutions is compared with growth in serum-containing standards. The recovery of B12 added to serum, incomplete when estimated from aqueous standards, is now complete and the variation in results from batch to batch is markedly reduced.

Various factors—such as medium, light, and inoculum—can affect growth in aqueous and serum solutions differently and are an important cause of variations between batches and laboratories.

Optimal conditions were studied and they are essential for the most sensitive and accurate assay, but if the results are estimated from serum-containing standards accurate values can be obtained even under less than optimal conditions.

Subnormal serum B12 concentrations can be detected visually as early as 24 hours after the start of assay. For diagnostic purposes the assay can be read at three days, provided that appropriate dilutions are used, conditions are optimal, and growth is measured in a 1 cm. cell.

Full text

PDF
14

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BANERJEE D. K., GHOSE S., GHOSH S. K., CHATTERJEA J. B. Free serum vitamin B12 level in certain hematologic disorders. Blood. 1960 May;15:630–636. [PubMed] [Google Scholar]
  2. BAURIEDEL W. R., PICKEN J. C., Jr, UNDERKOFLER L. A. Reactions of cyanocobalamin and aquocobalamin with proteins. Proc Soc Exp Biol Med. 1956 Mar;91(3):377–381. doi: 10.3181/00379727-91-22268. [DOI] [PubMed] [Google Scholar]
  3. COOPER B. A. Studies with a more rapid method of vitamin B12 assay utilizing Euglena gracilis. J Clin Pathol. 1959 Mar;12(2):153–156. doi: 10.1136/jcp.12.2.153. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. DAVIS R. E., KELLY A. The microbiological assay of serum folic acid activity. Aust J Exp Biol Med Sci. 1962 Dec;40:437–444. doi: 10.1038/icb.1962.48. [DOI] [PubMed] [Google Scholar]
  5. GIRDWOOD R. H. Microbiological methods of assay in clinical medicine with particular reference to the investigation of deficiency of vitamin B12 and folic acid. Scott Med J. 1960 Jan;5:10–22. doi: 10.1177/003693306000500103. [DOI] [PubMed] [Google Scholar]
  6. HEINRICH H. C., LAHANN H. Physiologie, Pathologie und biochemischer Wirkungsmechanismus der B12-Vitamine. I. Physiologie der B12-Vitamine. Z Vitam Horm Fermentforsch. 1954;6(2-3):126–200. [PubMed] [Google Scholar]
  7. KILLANDER A. Mikrobiologisk bestämning av vitamin B12 i serum och urin med Euglena gracilis var. bacillaris; preliminärt meddelande. Sven Lakartidn. 1953 Oct 30;50(44):2260–2264. [PubMed] [Google Scholar]
  8. LEAR A. A., HARRIS J. W., CASTLE W. B., FLEMING E. M. The serum vitamin B12 concentration in pernicious anemia. J Lab Clin Med. 1954 Nov;44(5):715–722. [PubMed] [Google Scholar]
  9. MATTHEWS D. M. Observations on the estimation of serum vitamin B12 using Lactobacillus leichmannii. Clin Sci. 1962 Feb;22:101–111. [PubMed] [Google Scholar]
  10. MILLER A. The in vitro binding of cobalt 60 labeled vitamin B12 by normal and leukemic sera. J Clin Invest. 1958 Apr;37(4):556–566. doi: 10.1172/JCI103638. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. MOLLIN D. L., ROSS G. I. M. The vitamin B12 concentrations of serum and urine of normals and of patients with megaloblastic anaemias and other diseases. J Clin Pathol. 1952 May;5(2):129–139. doi: 10.1136/jcp.5.2.129. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. NICHOLAS D. R., PITNEY W. R. Microbiological assay of vitamin B12 content of serum using Euglena gracilis. Aust J Exp Biol Med Sci. 1958 Dec;36(6):603–608. doi: 10.1038/icb.1958.65. [DOI] [PubMed] [Google Scholar]
  13. PITNEY W. R., BEARD M. F. Serum and urine concentrations of vitamin B12 following oral administration of the vitamin. J Clin Nutr. 1954 Mar-Apr;2(2):89–96. doi: 10.1093/ajcn/2.2.89. [DOI] [PubMed] [Google Scholar]
  14. PITNEY W. R., BEARD M. F., VAN LOON E. J. Observations on the bound form of vitamin B12 in human serum. J Biol Chem. 1954 Mar;207(1):143–152. [PubMed] [Google Scholar]
  15. RACCUGLIA G., SACKS M. S. Vitamin B12 binding capacity of normal and leukemic sera. J Lab Clin Med. 1957 Jul;50(1):69–77. [PubMed] [Google Scholar]
  16. ROSS G. I. M. Vitamin B12 assay in body fluids. Nature. 1950 Aug 12;166(4215):270–271. doi: 10.1038/166270a0. [DOI] [PubMed] [Google Scholar]
  17. SHINTON N. K. Total serum vitamin B12 concentration in normal human adult serum assayed by Euglena gracilis. Clin Sci. 1959 Aug;18:389–398. [PubMed] [Google Scholar]
  18. SPRAY G. H. An improved method for the rapid estimation of vitamin B12 in serum. Clin Sci. 1955 Nov;14(4):661–667. [PubMed] [Google Scholar]
  19. ØSTERGAARD KRISTENSEN H. P. Investigations into the Euglena gracilis method for quantitative assay of vitamin B12. Acta Physiol Scand. 1955;33(2-3):232–237. doi: 10.1111/j.1748-1716.1955.tb01205.x. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Pathology are provided here courtesy of BMJ Publishing Group

RESOURCES